I'm hesitant to invest in LLY

Like
1
Favorite

I'm hesitant to invest in LLY and NVO stocks because I'm not yet familiar with these companies.

# Can LLY & NVO Continue to Thrive After Earnings?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Top
Latest

Miller
·05-02
LLY是龙头，NVO当仁不让，两家公司都是减肥药和糖尿病抑制药物的领导者，减肥药NVO更胜一筹。
Reply
Like
Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":301502444765376,"tweetId":"301502444765376","gmtCreate":1714628500659,"gmtModify":1714628505253,"author":{"id":4159970598736412,"authorId":4159970598736412,"authorIdStr":"4159970598736412","name":"Spiders","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.25","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":791,"starInvestorFlag":true,"starInvestorFollowerNum":542,"starInvestorOrderShareNum":166,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":13.02,"showRor":true,"investmentPhilosophy":"I invest with my brain, not my heart ","winRationPercentage":90,"navOrReporedYield":0,"tradeVolumeEst":0},"themes":[{"themeId":"d822d5c696d142e19279a3443143a214","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"Can LLY & NVO Continue to Thrive After Earnings?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":d822d5c696d142e19279a3443143a214}&rnconfig={\"headerBarHidden\": true}","description":"LLY and NVO will release their financial reports this Tuesday and Thursday. \nBoth of these weight-loss drug companies have risen by over 20% since the beginning of the year.\n----------------------\nIs weight-loss drug, like AI, a main investment theme this year? \nWould you buy weight-loss drug companies? \nCan Eil Lilly return to $800?","image":"https://community-static.tradeup.com/news/41769bc30d50092aae45ad020b371b2e"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>I'm hesitant to invest in LLY and NVO stocks because I'm not yet familiar with these companies.</p></body></html>","htmlText":"<html><head></head><body><p>I'm hesitant to invest in LLY and NVO stocks because I'm not yet familiar with these companies.</p></body></html>","text":"I'm hesitant to invest in LLY and NVO stocks because I'm not yet familiar with these companies.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/301502444765376","repostId":0,"isVote":1,"tweetType":1,"viewCount":84,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":79,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":301595252678712,"gmtCreate":1714637740049,"gmtModify":1714637740049,"authorId":11307867536043,"author":{"id":11307867536043,"authorId":11307867536043,"name":"Miller","avatar":"https://static.laohu8.com/cee66e75fe7e4ea41b12cf6399c33dcf","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":301502444765376,"type":1,"supId":0,"prevId":0,"content":"LLY是龙头，NVO当仁不让，两家公司都是减肥药和糖尿病抑制药物的领导者，减肥药NVO更胜一筹。","text":"LLY是龙头，NVO当仁不让，两家公司都是减肥药和糖尿病抑制药物的领导者，减肥药NVO更胜一筹。","html":"LLY是龙头，NVO当仁不让，两家公司都是减肥药和糖尿病抑制药物的领导者，减肥药NVO更胜一筹。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}